[1]
“THERAPEUTIC VALUE OF COMBINED THERAPY WITH DEFERASIROX AND SILYMARIN ON IRON OVERLOAD IN CHILDREN WITH BETA THALASSEMIA”, Mediterr J Hematol Infect Dis, vol. 5, no. 1, p. e2013065, Nov. 2013, doi: 10.4084/mjhid.2013.065.